GC Pharma
| GC Pharma
|
|
|---|---|
 |
|
| legal form | Public company |
| founding | 1967 |
| Seat |
Yongin , South Korea
|
| management | Eun Chul Huh |
| sales | 369.69 trillion Won (5.3 billion euros ) |
| Branch | Biopharma |
| Website | www.globalgreencross.com |
| Status: 2019 | |
GC Pharma ( Green Cross Corporation ) is a biopharmaceutical company founded in 1967 with headquarters in Yongin , South Korea. GC Pharma specializes in developing and commercializing vaccines, protein therapies and therapeutic antibodies for oncology and infectious diseases.
The company was founded on October 5, 1967 as "Sudo Microorganism Medical Supplies Co." and in 1971 renamed "Green Cross". The current president is Eun Chul Huh (predecessor: Huh Young-sup ). It is traded on the Korea Exchange under the identifier "KRX: 006280" .
GC Pharma is the largest manufacturer of plasma protein products in Asia. In December 2019, GC Pharma cooperated with the Estonian fitness blockchain company Lympo in the fight against obesity.